{"id":5451,"date":"2026-02-04T06:51:46","date_gmt":"2026-02-04T13:51:46","guid":{"rendered":"https:\/\/calgary1.one\/?p=5451"},"modified":"2026-02-04T07:34:47","modified_gmt":"2026-02-04T14:34:47","slug":"a-new-era-in-neurosurgery-from-fluid-biomed-inc","status":"publish","type":"post","link":"https:\/\/calgary1.one\/en\/eternal\/a-new-era-in-neurosurgery-from-fluid-biomed-inc-5451","title":{"rendered":"A new era in neurosurgery from Fluid Biomed Inc."},"content":{"rendered":"\n<p>Most Canadians are well-acquainted with the achievements of Fluid Biomed Inc., an ambitious a <a href=\"https:\/\/calgary1.one\/en\/business\">Canadian MedTech company<\/a>. What began in 2012 as a research spin-off from the University of Calgary has evolved into a global innovator. The founders set out with a clear mission: to develop a safer, more effective treatment for brain aneurysms. Their solution? The world\u2019s first bioabsorbable (self-dissolving) neurovascular stent. <a href=\"https:\/\/calgary1.one\/en\/\">Calgary1.one<\/a> explores how this local startup is ushering in a new era of neurosurgery and innovative business.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_74 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<label for=\"ez-toc-cssicon-toggle-item-6a2dc234937f2\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a2dc234937f2\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/calgary1.one\/en\/eternal\/a-new-era-in-neurosurgery-from-fluid-biomed-inc-5451\/#The_Origins_of_Fluid_Biomed_Inc\" >The Origins of Fluid Biomed Inc.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/calgary1.one\/en\/eternal\/a-new-era-in-neurosurgery-from-fluid-biomed-inc-5451\/#Tackling_Brain_Aneurysms\" >Tackling Brain Aneurysms<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/calgary1.one\/en\/eternal\/a-new-era-in-neurosurgery-from-fluid-biomed-inc-5451\/#Clinical_Trials_and_Growth\" >Clinical Trials and Growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/calgary1.one\/en\/eternal\/a-new-era-in-neurosurgery-from-fluid-biomed-inc-5451\/#Contact_Information\" >Contact Information<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Origins_of_Fluid_Biomed_Inc\"><\/span>The Origins of Fluid Biomed Inc.<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The company was co-founded in 2012 by Dr. John Wong and Dr. Alim Mitha, two neurosurgeon research partners from the University of Calgary.<\/p>\n\n\n\n<p>Dr. Alim Mitha serves as President, Chief Technology Officer, and Co-founder. He is an Associate Professor at the University of Calgary and leads a dedicated campus laboratory that collaborates with the Hotchkiss Brain Institute and the Libin Cardiovascular Institute.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"422\" src=\"https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/mitch.png\" alt=\"Dr. Alim Mitha\" class=\"wp-image-5433\" srcset=\"https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/mitch.png 330w, https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/mitch-235x300.png 235w\" sizes=\"auto, (max-width: 330px) 100vw, 330px\" \/><\/figure>\n\n\n\n<p>Dr. John Wong is the CEO and Co-founder. In addition to being an MD and MBA, he is an Associate Professor in the Departments of Clinical Neurosciences and Radiology at the <a href=\"https:\/\/calgary1.one\/en\/eternal\/cumming-school-of-medicine-4900\">Cumming School of Medicine<\/a>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"407\" height=\"572\" src=\"https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/vong.png\" alt=\"Dr. John Wong\" class=\"wp-image-5436\" srcset=\"https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/vong.png 407w, https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/vong-213x300.png 213w\" sizes=\"auto, (max-width: 407px) 100vw, 407px\" \/><\/figure>\n\n\n\n<p>Fluid Biomed Inc. is a medical device developer focused on healing blood vessels. These neurosurgeons engineered a polymer-based stent capable of diverting blood flow away from weak brain aneurysms, allowing the vessel to heal naturally.<\/p>\n\n\n\n<p>The duo continues to work tirelessly to support stroke survivors. This drive to improve patient outcomes led these <a href=\"https:\/\/icalgary.net\/en\/eternal-top-researchers-at-the-university-of-calgary\" target=\"_blank\" rel=\"noopener\">top researchers at the University of Calgary<\/a> to pioneer their unique stent technology.<\/p>\n\n\n\n<p>In late 2025, the company strengthened its leadership by appointing John Kilcoyne as independent Board Chair. An industry veteran, Kilcoyne brings over 40 years of executive experience in the medical device sector.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1009\" height=\"408\" src=\"https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/1.png\" alt=\"Fluid Biomed Team\" class=\"wp-image-5439\" srcset=\"https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/1.png 1009w, https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/1-300x121.png 300w, https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/1-768x311.png 768w, https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/1-696x281.png 696w\" sizes=\"auto, (max-width: 1009px) 100vw, 1009px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tackling_Brain_Aneurysms\"><\/span>Tackling Brain Aneurysms<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Fluid Biomed\u2019s researchers developed the world\u2019s first polymer flow-diverting stent to address a critical health crisis. Statistics show that up to 5% of the population may suffer from brain aneurysms, which can lead to strokes. In the U.S. alone, approximately 6.5 million people have unruptured aneurysms. Every year, about 300,000 people suffer a rupture\u2014tragically, one-third of these cases are fatal.<\/p>\n\n\n\n<p>A multidisciplinary team of neurosurgeons, scientists, and engineers met this challenge by creating a hybrid polymer-metal flow diverter. This innovative device uses a soluble polymer combined with a minimal metal framework for superior healing and better vessel visualization. The technology works much like dissolvable stitches: it performs its function and then disappears.<\/p>\n\n\n\n<p>Fluid Biomed Inc. is confident that this technology will significantly improve the quality of life for patients globally. Key advantages include:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Unlike traditional metal stents that remain in the body as permanent foreign objects, Fluid Biomed\u2019s smart polymer stent supports the vessel until it heals, then naturally dissolves.<\/li>\n\n\n\n<li>The stent acts as a smart traffic sign for blood, diverting the main flow away from the aneurysm to reduce stroke risk while ensuring surrounding brain areas receive full blood supply.<\/li>\n\n\n\n<li>The polymer is invisible on X-rays, meaning it doesn&#8217;t cause the glare or interference often seen with metal stents during MRI or CT scans. This allows doctors to get a crystal-clear view of the brain.<\/li>\n\n\n\n<li>Because the body doesn&#8217;t react to it as a permanent foreign object, patients may be freed from the lifelong medication often required with metal implants.<\/li>\n\n\n\n<li>The device is highly flexible and self-expanding, eliminating the need for complex balloon inflation inside the delicate vessels of the brain.<\/li>\n<\/ol>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"962\" height=\"641\" src=\"https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/rysunok28.jpg\" alt=\"Medical visualization\" class=\"wp-image-5442\" srcset=\"https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/rysunok28.jpg 962w, https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/rysunok28-300x200.jpg 300w, https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/rysunok28-768x512.jpg 768w, https:\/\/cdn.calgary1.one\/wp-content\/uploads\/sites\/39\/2026\/02\/rysunok28-696x464.jpg 696w\" sizes=\"auto, (max-width: 962px) 100vw, 962px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Clinical_Trials_and_Growth\"><\/span>Clinical Trials and Growth<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The first successful human implantations of the polymer neurovascular stent took place in 2023. Following a successful $27 million Series A financing round in December 2024, the company has focused on expanding its clinical trials through 2025 and 2026. This research is backed by a powerhouse investment group led by Amplitude Ventures, along with IAG Capital Partners, LifeArc Ventures, ShangBay Capital, and METIS Innovative.<\/p>\n\n\n\n<p>Data published in the Journal of NeuroInterventional Surgery confirms the technology\u2019s high safety profile and its effectiveness in securely sealing off aneurysms.<\/p>\n\n\n\n<p>As of 2026, the company is finalizing the data collection required for regulatory certification. Current projections suggest that Fluid Biomed will submit applications for commercial use within the next 12 to 24 months.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<div class=\"youtube-embed\" data-video_id=\"SttfS-CWDOc\"><iframe loading=\"lazy\" title=\"Meet Fluid Biomed: a CDL-Rockies Alumni Company\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/SttfS-CWDOc?feature=oembed&#038;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Contact_Information\"><\/span>Contact Information<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Fluid Biomed Inc. is headquartered in Calgary at 3710 33 St NW. The office is open weekdays from 9:00 AM to 5:00 PM and closed on weekends.<\/p>\n\n\n\n<p>To reach the team, you can email INFO@FLUIDBIOMED.COM or complete the <a href=\"https:\/\/fluidbiomed.com\/contact\/\" target=\"_blank\" rel=\"noopener\">online contact form<\/a>.<\/p>\n\n\n\n<p>Fluid Biomed stands as a prime example of how academic research can be transformed into a life-saving commercial product. Their technology is poised to redefine the gold standard for neurovascular care worldwide, promising better patient outcomes and reducing the long-term healthcare costs associated with repeat surgeries.<\/p>\n\n\n\n<p>Sources:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.ucalgary.ca\/uceed\/about\/portfolio\/fluid-biotech\" target=\"_blank\" rel=\"noopener\">https:\/\/www.ucalgary.ca\/uceed\/about\/portfolio\/fluid-biotech<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/fluidbiomed.com\/our-story\/our-story\/\" target=\"_blank\" rel=\"noopener\">https:\/\/fluidbiomed.com\/our-story\/our-story\/<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/lifearcventures.com\/fluid-biomed-inc-raises-27-million-usd-in-oversubscribed-series-a-financing-to-advance-worlds-first-bioabsorbable-polymer-based-stent-to-treat-brain-aneurysms\/\" target=\"_blank\" rel=\"noopener\">https:\/\/lifearcventures.com\/fluid-biomed-inc-raises-27-million-usd-in-oversubscribed-series-a-financing-to-advance-worlds-first-bioabsorbable-polymer-based-stent-to-treat-brain-aneurysms\/<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/educationnewscanada.com\/article\/education\/level\/university\/1\/1125321\/fluid-biomed-from-a-research-project-to-an-innovative-health-care-tech-business.html\" target=\"_blank\" rel=\"noopener\">https:\/\/educationnewscanada.com\/article\/education\/level\/university\/1\/1125321\/fluid-biomed-from-a-research-project-to-an-innovative-health-care-tech-business.html<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.lifesciencemarketresearch.com\/insights\/the-memo-fluid-biomed-pioneering-bioabsorbable-stents-to-cure-brain-aneurysms\" target=\"_blank\" rel=\"noopener\">https:\/\/www.lifesciencemarketresearch.com\/insights\/the-memo-fluid-biomed-pioneering-bioabsorbable-stents-to-cure-brain-aneurysms<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Most Canadians are well-acquainted with the achievements of Fluid Biomed Inc., an ambitious a Canadian MedTech company. What began in 2012 as a research spin-off from the University of Calgary has evolved into a global innovator. The founders set out with a clear mission: to develop a safer, more effective treatment for brain aneurysms. Their [&hellip;]<\/p>\n","protected":false},"author":446,"featured_media":5431,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1164],"tags":[4083,4072,4088,4084,4059,4086,4092,4089,4087,4090,4085,4091],"moimportance":[82,78,81],"motype":[1158],"moformat":[2510],"class_list":{"0":"post-5451","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business","8":"tag-aneurysm-treatment","9":"tag-bioabsorbable-stent-2","10":"tag-brain-aneurysm","11":"tag-brain-aneurysm-treatment-3","12":"tag-fluid-biomed","13":"tag-funding","14":"tag-neurovascular-stent","15":"tag-neurovascular-technologies","16":"tag-research","17":"tag-self-absorbable-polymer","18":"tag-trials","19":"tag-university-of-calgary-spin-off-3","20":"moimportance-aktualna-bilshe-roku","21":"moimportance-golovna-novina","22":"moimportance-retranslyacziya-v-agregatori","23":"motype-eternal","24":"moformat-c-l"},"modified_by":"Anna Moshak","_links":{"self":[{"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/posts\/5451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/users\/446"}],"replies":[{"embeddable":true,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/comments?post=5451"}],"version-history":[{"count":2,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/posts\/5451\/revisions"}],"predecessor-version":[{"id":5454,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/posts\/5451\/revisions\/5454"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/media\/5431"}],"wp:attachment":[{"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/media?parent=5451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/categories?post=5451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/tags?post=5451"},{"taxonomy":"moimportance","embeddable":true,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/moimportance?post=5451"},{"taxonomy":"motype","embeddable":true,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/motype?post=5451"},{"taxonomy":"moformat","embeddable":true,"href":"https:\/\/calgary1.one\/en\/wp-json\/wp\/v2\/moformat?post=5451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}